logo
AI Icon𝛼SK or Search
ENTITY

City Therapeutics (CTY US)

7
Analysis
Health Care • United States
City Therapeutics, Inc. is a biotechnology company. The Company develops RNA interference therapeutics designed to silence the expression of disease-relevant proteins for the benefit of patients in need. City Therapeutics operates in the United States.
more
bullish•City Therapeutics
•09 Oct 2026 21:16

City Therapeutics (CTY): RNAi Ambitions, City Therapeutics Launches IPO With $956M Target Valuation

City Therapeutics seeks up to a $956M IPO valuation to advance RNAi medicines targeting serious diseases, leveraging an experienced team,...

Logo
IPO Boutique
96 Views
Share
bullish•City Therapeutics
•08 Oct 2026 14:13

Primer: City Therapeutics (CTY US) - Oct 2026

City Therapeutics, Inc. (Nasdaq: CTY) is a clinical-stage biotechnology company pioneering next-generation RNA interference (RNAi) medicines...

Logo
Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x